Calcific Uremic Arteriolopathy
7 clinical trials · Condition
◉ Watch Calcific Uremic Arteriolopathy
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study of SNF472 for Calciphylaxis (NCT04195906) | Sanifit Therapeutics S. A. | 2020-02-12 |
| Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis (NCT04592640) | The First Affiliated Hospital with Nanjing Medical University | 2018-09-17 |
| Partners Calciphylaxis Biobank (NCT03032835) | Massachusetts General Hospital | 2017-01-01 |
| Phase 2 Study With SNF472 in Calciphylaxis Patients (NCT02790073) | Sanifit Therapeutics S. A. | 2016-05-01 |
| Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy (NCT02278692) | Massachusetts General Hospital | 2015-03-01 |
| Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy (NCT02527213) | American Regent, Inc. | 2015-01-30 |
Track Calcific Uremic Arteriolopathy automatically
Every clearance here is in the API, with alerts when new ones post.